Home » Topics » Regulatory

Regulatory
RSS

IL-2 treatment dramatically effective in AIDS patients

Nov. 8, 1996

MiKasome cleared for clinical trials in HIV-positive patients

Nov. 8, 1996

New, more convenient testosterone transdermal patch submitted for approval

Nov. 1, 1996

Pfizer 5-HT reuptake inhibitor approved in U.S. for new indication

Nov. 1, 1996

Cefzil approved for new indication in U.S.

Nov. 1, 1996

Additional clinical data support the potential of DepoCyt in neoplastic meningitis

Oct. 25, 1996

Sulfasalazine approved for rheumatoid arthritis

Oct. 25, 1996

Expanded indications for Abelcet

Oct. 25, 1996

Cholestyramine treatment of peri-anal irritation in an infant

Oct. 25, 1996

Anesta's Actiq on schedule for launch

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...